Live feed
Filing
SC 13G
SC 13G0000904454-14-000785·DMK PHARMACEUTICALS Corp
Schedule 13G ownership disclosure
Adamis Pharmaceuticals Corp
Security class unavailable · CUSIP: 00547W208
Event date: 2014-10-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,168,566
- Percent of class
- 11.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-14-000785
- Form type
- SC 13G
- Filer
- DMK PHARMACEUTICALS Corp
- CIK
- CIK 887247
- Filed
- Dec 05, 2014
- Reporting period
- Oct 15, 2014
- Description
- Schedule 13G beneficial ownership